Richard Lanigan

Rich has over 25 years of medical device experience, including executive commercial roles and general management responsibility. Prior to joining Gynesonics, in 2013 he served as a global commercial operations strategic consultant at IDEV Technologies, a private company focused on the peripheral vascular market, which was acquired by Abbott Vascular in 2013. During 2011-2012 he was General Manager of Orthopedic & Woundcare division of Synovis Life Technologies. The company, which developed chemically crosslinked tissue products used in a range of surgical applications, was acquired by Baxter International in 2012. From 2001 through the beginning of 2011 he served in positions of increasing commercial responsibility, and as a corporate officer and President at Cardiogenesis Corporation. The company was acquired by Cryolife Corporation in 2011.

Rich earned a B.A. (Finance) from the University of Notre Dame and a M.S. in Systems Management from the University of Southern California.